HIV integrase/DNA complexes and concerted integration
HIV integrase/DNA complexes and concerted integration
批准号:
7860293
负责人:
DUANE P GRANDGENETT
金额:
$22.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-05 至 2012-05-31
关键词:
AbbreviationsAddressAffectAmino AcidsAtomic Force MicroscopyBindingBiochemicalBiological ModelsCell NucleusCellsChemicalsChromosomesCircular DNACleaved cellComplementary DNAComplexComputer SimulationConsensus SequenceCoupledCytoplasmDNADNA IntegrationDNA SequenceDefectDigestionDinucleoside PhosphatesDipeptidesDockingFluorescence Resonance Energy TransferFosteringGelGenomeHIV-1In VitroIntegraseInvestigationKnowledgeLabelLong Terminal RepeatsMacromolecular ComplexesMass Spectrum AnalysisMeasurementMeasuresModelingMolecularMolecular StructureNuclearNucleoproteinsPathway interactionsPatternProcessPropertyProteinsProvirusesSepharoseSiteSite-Directed MutagenesisStructureStructure-Activity RelationshipSuperhelical DNASynapsesTechniquesTerminal Repeat SequencesTestingTimeViralViral ProteinsViruscrosslinkdimerfluorophorein vivoinsightmutantnucleocytoplasmic transportpublic health relevancereconstitutionresearch studytranscriptional coactivator p75viral DNAviral RNA
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In HIV-1 infected cells, the viral RNA is reverse transcribed into a 10 kbp linear blunt-ended DNA followed by the formation of the cytoplasmic preintegration complex (PIC). The viral integrase (IN) within the PIC cleaves a dinucleotide from the 3' OH ends of the viral DNA prior to nuclear transport. IN inserts the two recessed ends in a concerted fashion into the host chromosome, producing the provirus. The cellular co- factor, LEDGF/p75, influences the ability of the PIC to select sites on the host chromosomes for integration. The IN-IN and IN-DNA interactions within the PIC critical for concerted integration and the effect of cellular co-factors on this process are not well defined at the biochemical and biophysical levels. We recently identified a nucleoprotein complex on native agarose gels where IN non-covalently juxtaposes two viral DNA ends that produces the synaptic complex (SC) that possesses properties associated with the PIC. We will study the assembly properties of the SC, investigate the ability of IN to protect the terminal U5 and U3 DNA sequences from DNaseI digestion and determine the molar ratios of chemically cross-linked dimers, tetramers and a larger-size multimer of IN located in the SC. A unique ~32 bp DNaseI protective footprint by IN in the SC suggests a structural relationship to the larger-size multimer. We will investigate the relationships between these cross-linked species to identify the unique inter-subunit residues responsible for formation of the tetramer, as determined by mass spectrometry studies of cross-linked tryptic dipeptides. In- gel fluorescence resonance energy transfer-derived distance measurements and atomic force microscopy will determine the topology of the two viral DNA ends within the SC. We expect to generate a structural paradigm describing the SC and its relationship to the PIC. We will define the cellular co-factor LEDGF/p75 physical interactions with the SC and determine if it affects the SC by measuring the distance between fluorophore- labeled DNA substrates in the SC. We will develop a model system to determine if LEDGF/p75 influences host-site selection on chromatinized supercoiled target DNA for concerted integration. We will study known Class II IN mutants in vitro that are catalytically active and possess post-nuclear entry defects. We will also determine the functionality of the unique residues identified in the cross-linked IN tetramer observed in the SC. Site-directed mutagenesis of these IN residues will be performed for probing of the PIC in vivo and the SC in vitro. The knowledge gain from the R21 studies will be used to further investigate the PIC and the involvement of cellular co-factors in integration. Completion of the R21/R33 studies will foster a necessary and achievable understanding of concerted integration both in vitro and in vivo. PUBLIC HEALTH RELEVANCE: We are building a platform of structural information to understand the HIV-1 synaptic complex (SC) capable of concerted integration. We will determine the IN subunit interactions within SC to define what residues are responsible for formation of the IN tetramer. The functionality of these residues will be investigated by site-directed mutagenesis to probe the PIC in vivo and the SC in vitro. We will determine if LEDGF/p75 physically interacts with SC and test whether it influences host-site selection on chromatinized supercoiled target DNA that contains HIV-1 host-site consensus sequences.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
The HIV-1 integrase monomer induces a specific interaction with LTR DNA for concerted integration.
HIV-1整合酶单体诱导与LTR DNA的特定相互作用进行协同整合。
DOI:
10.1021/bi201247f
发表时间:
2011-11-15
期刊:
BIOCHEMISTRY
影响因子:
2.9
作者:
[Pandey, Krishan K., Bera, Sibes, Grandgenett, Duane P.]
通讯作者:
Grandgenett, Duane P.
DOI:
10.1371/journal.pone.0056892
发表时间:
2013
期刊:
PloS one
影响因子:
3.7
作者:
[Shi K, Pandey KK, Bera S, Vora AC, Grandgenett DP, Aihara H]
通讯作者:
Aihara H
Physical trapping of HIV-1 synaptic complex by different structural classes of integrase strand transfer inhibitors.
不同结构类别的整合酶链转移抑制剂对 HIV-1 突触复合体的物理捕获。
DOI:
10.1021/bi100514s
发表时间:
2010
期刊:
Biochemistry
影响因子:
2.9
作者:
[Pandey,KrishanK, Bera,Sibes, Vora,AjaykumarC, Grandgenett,DuaneP]
通讯作者:
Grandgenett,DuaneP
Raltegravir in HIV-1 infection: Safety and Efficacy in Treatment-naïve Patients.
拉替拉韦治疗 HIV-1 感染:对初治患者的安全性和有效性。
DOI:
10.4137/cmrt.s5022
发表时间:
2011
期刊:
Clinical medicine reviews in therapeutics
影响因子:
--
作者:
[Pandey,KrishanK]
通讯作者:
Pandey,KrishanK
Assembly of HIV intasomes
-
批准号:9294971
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2016
-
负责人:DUANE P GRANDGENETT
-
依托单位:
Assembly of HIV intasomes
-
批准号:9203230
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2016
-
负责人:DUANE P GRANDGENETT
-
依托单位:
HIV Integrase Structural Biology
-
批准号:8410454
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2012
-
负责人:DUANE P GRANDGENETT
-
依托单位:
HIV Integrase Structural Biology
-
批准号:8495924
-
项目类别:
-
资助金额:$17.63万
-
财政年份:2012
-
负责人:DUANE P GRANDGENETT
-
依托单位:
HIV integrase/DNA complexes and concerted integration
-
批准号:7622272
-
项目类别:
-
资助金额:$20.28万
-
财政年份:2009
-
负责人:DUANE P GRANDGENETT
-
依托单位:
HIV-1 INTEGRATION PROTEIN
-
批准号:3146296
-
项目类别:
-
资助金额:$16.39万
-
财政年份:1991
-
负责人:DUANE P GRANDGENETT
-
依托单位:
HIV-1 INTEGRATION PROTEIN
-
批准号:6169661
-
项目类别:
-
资助金额:$21.45万
-
财政年份:1991
-
负责人:DUANE P GRANDGENETT
-
依托单位:
HIV-1 Integration
-
批准号:6892130
-
项目类别:
-
资助金额:$25.73万
-
财政年份:1991
-
负责人:DUANE P GRANDGENETT
-
依托单位:
HIV-1 INTEGRATION PROTEIN
-
批准号:2066285
-
项目类别:
-
资助金额:$18.34万
-
财政年份:1991
-
负责人:DUANE P GRANDGENETT
-
依托单位:
HIV-1 INTEGRATION PROTEIN
-
批准号:2066282
-
项目类别:
-
资助金额:$17.14万
-
财政年份:1991
-
负责人:DUANE P GRANDGENETT
-
依托单位:
HIV-1 INTEGRATION PROTEIN
-
批准号:2672061
-
项目类别:
-
资助金额:$19.84万
-
财政年份:1991
-
负责人:DUANE P GRANDGENETT
-
依托单位:
HIV-1 INTEGRATION PROTEIN
-
批准号:2429397
-
项目类别:
-
资助金额:$19.07万
-
财政年份:1991
-
负责人:DUANE P GRANDGENETT
-
依托单位:
HIV-1 INTEGRATION PROTEIN
-
批准号:2886703
-
项目类别:
-
资助金额:$20.63万
-
财政年份:1991
-
负责人:DUANE P GRANDGENETT
-
依托单位:
HIV-1 INTEGRATION PROTEIN
-
批准号:3146294
-
项目类别:
-
资助金额:$15.34万
-
财政年份:1991
-
负责人:DUANE P GRANDGENETT
-
依托单位:
HIV-1 Integration
-
批准号:6510618
-
项目类别:
-
资助金额:$25.75万
-
财政年份:1991
-
负责人:DUANE P GRANDGENETT
-
依托单位:
HIV-1 Integration
-
批准号:6631913
-
项目类别:
-
资助金额:$25.73万
-
财政年份:1991
-
负责人:DUANE P GRANDGENETT
-
依托单位:
HIV-1 Integration
-
批准号:6732068
-
项目类别:
-
资助金额:$25.73万
-
财政年份:1991
-
负责人:DUANE P GRANDGENETT
-
依托单位:
HIV-1 INTEGRATION PROTEIN
-
批准号:2066283
-
项目类别:
-
资助金额:$17.81万
-
财政年份:1991
-
负责人:DUANE P GRANDGENETT
-
依托单位:
HIV-1 INTEGRATION PROTEIN
-
批准号:3146295
-
项目类别:
-
资助金额:$15.66万
-
财政年份:1991
-
负责人:DUANE P GRANDGENETT
-
依托单位:
HIV-1 Integration
-
批准号:6408646
-
项目类别:
-
资助金额:$24.61万
-
财政年份:1991
-
负责人:DUANE P GRANDGENETT
-
依托单位:
海外基金